BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Toguri JT, Caldwell M, Kelly ME. Turning Down the Thermostat: Modulating the Endocannabinoid System in Ocular Inflammation and Pain. Front Pharmacol 2016;7:304. [PMID: 27695415 DOI: 10.3389/fphar.2016.00304] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Zhou J, Kamali K, Lafreniere JD, Lehmann C. Real-Time Imaging of Immune Modulation by Cannabinoids Using Intravital Fluorescence Microscopy. Cannabis Cannabinoid Res 2021;6:221-32. [PMID: 34042507 DOI: 10.1089/can.2020.0179] [Reference Citation Analysis]
2 Borowska-Fielding J, Murataeva N, Smith B, Szczesniak AM, Leishman E, Daily L, Toguri JT, Hillard CJ, Romero J, Bradshaw H, Kelly MEM, Straiker A. Revisiting cannabinoid receptor 2 expression and function in murine retina. Neuropharmacology 2018;141:21-31. [PMID: 30121200 DOI: 10.1016/j.neuropharm.2018.08.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
3 Tran BN, Maass M, Musial G, Stern ME, Gehlsen U, Steven P. Topical application of cannabinoid-ligands ameliorates experimental dry-eye disease. Ocul Surf 2021;23:131-9. [PMID: 34922011 DOI: 10.1016/j.jtos.2021.12.008] [Reference Citation Analysis]
4 Taskar P, Adelli G, Patil A, Lakhani P, Ashour E, Gul W, ElSohly M, Majumdar S. Analog Derivatization of Cannabidiol for Improved Ocular Permeation. J Ocul Pharmacol Ther 2019;35:301-10. [PMID: 30998110 DOI: 10.1089/jop.2018.0141] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Nguyen AX, Wu AY. Cannabis and the Cornea. Ocul Immunol Inflamm 2020;:1-6. [PMID: 32159404 DOI: 10.1080/09273948.2020.1726969] [Reference Citation Analysis]
6 Lafreniere JD, Kelly MEM. Potential for endocannabinoid system modulation in ocular pain and inflammation: filling the gaps in current pharmacological options. Neuronal Signal 2018;2:NS20170144. [PMID: 32714590 DOI: 10.1042/NS20170144] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
7 Scuteri D, Rombolà L, Hamamura K, Sakurada T, Watanabe C, Sakurada S, Guida F, Boccella S, Maione S, Gallo Afflitto G, Nucci C, Tonin P, Bagetta G, Corasaniti MT. Is there a rational basis for cannabinoids research and development in ocular pain therapy? A systematic review of preclinical evidence. Biomed Pharmacother 2021;146:112505. [PMID: 34891121 DOI: 10.1016/j.biopha.2021.112505] [Reference Citation Analysis]
8 Mobed A, Kohansal F, Ahmadalipour A, Hasanzadeh M, Zargari F. Bioconjugation of 2-arachidonoyl glycerol (2-AG) biotinylated antibody with gold nano-flowers toward immunosensing of 2-AG in human plasma samples: A novel immuno-platform for the screening of immunomodulation and neuroprotection using biosensing. Anal Methods 2021;13:311-21. [DOI: 10.1039/d0ay02135k] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Kelly MEM, Lehmann C, Zhou J. The Endocannabinoid System in Local and Systemic Inflammation. Colloquium Series on Integrated Systems Physiology: From Molecule to Function 2017;9:i-192. [DOI: 10.4199/c00151ed1v01y201702isp074] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
10 Thapa D, Cairns EA, Szczesniak AM, Toguri JT, Caldwell MD, Kelly MEM. The Cannabinoids Δ8THC, CBD, and HU-308 Act via Distinct Receptors to Reduce Corneal Pain and Inflammation. Cannabis Cannabinoid Res 2018;3:11-20. [PMID: 29450258 DOI: 10.1089/can.2017.0041] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
11 Soderstrom K, Soliman E, Van Dross R. Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms. Front Pharmacol 2017;8:720. [PMID: 29066974 DOI: 10.3389/fphar.2017.00720] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]